medigraphic.com

2000, Number 1

<< Back Next >>

Enf Infec Microbiol 2000; 20 (1)

Immunization in the reproductive years

Arredondo GJL, Flores CME

Language: Spanish
References: 23
Page: 14-23
PDF size: 52.68 Kb.


ABSTRACT

Vaccination is an effort with a noble goal: to protect a population –children or adults, men or women- against diseases that have effective vaccines so that they have a better future. Pediatric vaccination has achieved great advances in preventig and eradicating certain diseases, and although there is adequate production and availability of vaccines for adolescents and adults, especially pregnant women, the actual vaccine coverage leaves much to be desired. This “break” in vaccine usage in those age groups is due to a variety of causes; this is especially notable in the vaccination in women during their reproductive years, a period which is not recognized as a particularly critical time in public health, even by physicians themselves and their patients. As the present time there are few formal recommendations for the vaccination of the population in their actively reproductive years, and these are limited to the vaccination against a few diseases in groups at high risk, either because of their advanced age or the conditions at which they work.


REFERENCES

  1. Ruíz-Gómez J, Ruíz Puente J, Kado Bell G, Galicia Aguilar O. La producción de vacunas en México. CONAVA. Gaceta Bimestral núm.19, julio-agosto, 1994.

  2. Boletín Sistema Nacional de Vigilancia Epidemiológica. Epidemiología. Sistema Único de Información núm. 6, vol. 15, 7 al 13 de febrero de 1999. Y arranca. Primera Semana Nacional de Salud 1999.

  3. Vacunas de uso actual y tendencias de la investigación para su desarrollo y mejoramiento. Boletín Sistema Nacional de Vigilancia Epidemiológica. Epidemiología. Sistema Único de Información núm. 29, vol. 15, 19 al 25 de julio de 1998.

  4. Arredondo García JL, Flores Collins ME, Galán Herrera JF. Prevención de las enfermedades infecciosas en pediatría. Programa de Actualización Continua en Infectología. PAC Infecto-1. Asociación Mexicana de Infectología y Microbiología Clínica, AC. Intersistemas, 1998.

  5. Centers for Disease Control and Prevention: Recommendation of the Advisory Committee on Immunization Practices (ACIP): Polyomielitis prevention. MMWR 1998;31:22-31.

  6. Centers for Disease Control and Prevention: Recommendation of the Advisory Committee on Immunization Practices (ACIP): Diphteria, tetanus, and pertussi: guidelines for vaccine prophylaxis and other preventive measures. MMWR 1991;40(RR- 10):1.

  7. Cody Cl, Baraff LJ, Cherry JD, et al. The nature and rate of adverse reactions associated with DTP and DT immnunization in infants and children. Pediatrics 1981;68:650.

  8. Hart PD, Sutherland Y. BCG vaccine in the prevention of tuberculosis in adolescence and early adult life. Final report for the Medical Research Council. Br Med J 1997;2:293-5.

  9. Centers for Disease Control and Prevention: Recommendation of the Advisory Committee on Immunization Practices (ACIP):Use of BCG vaccines in the control of tuberculosis: a joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis. MMWR 1988;37:663-9.

  10. Figueroa DR, Hernández TM, Arredondo GJL. Evaluación neurológica de niños con exposición intrauterina a varicela durante las primeras 20 semanas de gestación. Perinatol Reprod Hum 1996;10: 208-15.

  11. Escobar GA, Valdespino Gómez JL, Sepúlveda-Amor J. Vacunas, ciencia y salud. Secretaría de Salud. Subsecretaría de Coordinación y Desarrollo. México, 1992.

  12. Asociación Española de Pediatría. Asociación Americana de Infectología. Manual de Vacunas en Pediatría. SLIPE,1997.

  13. Centers for Disease Control and Prevention. Progress toward the global elimination of neonatal tetanus, 1989-1993. MMWR 1994;43:885-94.

  14. Reyes-Hidalgo E, Flores-Collins ME. Tétanos. México: El Manual Moderno, 1982.

  15. Arredondo-García JL, Flores-Collins ME, Galán-Herrera JF. Manual del vacunador. (En prensa).

  16. Yáñez-Velasco LB. Programa de micobacteriosis. Sistema Nacional de Vigilancia Epidemiológica. Epidemiología. Sistema Único de Información núm. 39, vol. 14, 21 al 27 de septiembre, 1997.

  17. Figueroa DR, Martínez VI, Villagrana ZR, Arredondo GJL. Tuberculosis of the female reproductive tract: effect on function. Int J Fertil 1996;4(4):430-6.

  18. Figueroa DR, Arredondo GJL. Pregnancy and tuberculosis influence of treatment on perinatal outcome. Am J Perinatol, 1998;15(5):303-6.

  19. Ortíz-Ibarra FJ, Figueroa DR, Lara SJ, Arredondo GJL,Ahued AJR. Prevalencia de marcadores serológicos de los virus de la hepatitis A, B, C y D en embarazadas. Salud Publica Mex 1996;38:317-22.

  20. Norma Oficial Mexicana NOM-011-SSA2-1993, para la prevención y control de la rabia. DO 25 de enero de 1995.

  21. CDC. Recommendations and reports. Update on adult immunization. Recommendations of the immunization practices Advisory Committe (ACIP). MMWR 1991;40(RR12): 1-52.

  22. Arredondo-García JL, Velázquez-Jones L. (Compiladores). Vacunas en Pediatría. México: Intersistemas, 1997.

  23. Norma Oficial Mexicana NOM-023-SSA2-1994, para el control, eliminación y erradicación de las enfermedades evitables por vacunación. DO 5 de julio de 1996.




2020     |     www.medigraphic.com